StockData
Equillium, Inc. logo

Equillium, Inc. (EQ) stock

EQNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 8/30
$1.10−0.11 (-9.09%)

Close on Nov 18, 2026Market cap $69.75MP/E –Yield –

Equillium net income

Net income is the profit left for shareholders after every expense, interest and tax.

Equillium's net income for the twelve months ending Jun 30, 2026 was -$18.01M. For fiscal 2025 it was -$22.40M. The highest annual figure on record is -$8.07M in fiscal 2024.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$22.40M–
FY2024Dec 31, 2024-$8.07M–
FY2023Dec 31, 2023-$13.34M–
FY2022Dec 31, 2022-$62.43M–
FY2021Dec 31, 2021-$39.05M–
FY2020Dec 31, 2020-$29.81M–
FY2019Dec 31, 2019-$25.60M–
FY2018Dec 31, 2018-$13.25M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$4.69M–
Q1 FY2026Mar 31, 2026-$5.31M–
Q4 FY2025Dec 31, 2025-$3.78M–
Q3 FY2025Sep 30, 2025-$4.23M–
Q2 FY2025Jun 30, 2025-$5.74M-1326.3%
Q1 FY2025Mar 31, 2025-$8.65M–
Q4 FY2024Dec 31, 2024-$5.79M–
Q3 FY2024Sep 30, 2024-$7.00K–
Q2 FY2024Jun 30, 2024$468.00K–
Q1 FY2024Mar 31, 2024-$2.73M–
Q4 FY2023Dec 31, 2023-$2.34M-184.5%
Q3 FY2023Sep 30, 2023-$3.71M–
Q2 FY2023Jun 30, 2023-$3.34M–
Q1 FY2023Mar 31, 2023-$3.94M–
Q4 FY2022Dec 31, 2022$2.77M–
Q3 FY2022Sep 30, 2022-$13.66M–
Q2 FY2022Jun 30, 2022-$14.13M–
Q1 FY2022Mar 31, 2022-$37.42M–
Q4 FY2021Dec 31, 2021-$10.62M–
Q3 FY2021Sep 30, 2021-$10.28M–
Q2 FY2021Jun 30, 2021-$9.16M–
Q1 FY2021Mar 31, 2021-$8.99M–
Q4 FY2020Dec 31, 2020-$8.92M–
Q3 FY2020Sep 30, 2020-$6.60M–
Q2 FY2020Jun 30, 2020-$6.46M–
Q1 FY2020Mar 31, 2020-$7.84M–
Q4 FY2019Dec 31, 2019-$7.57M–
Q3 FY2019Sep 30, 2019-$6.01M–
Q2 FY2019Jun 30, 2019-$6.07M–
Q1 FY2019Mar 31, 2019-$5.95M–
Q4 FY2018Dec 31, 2018-$4.99M–
Q3 FY2018Sep 30, 2018-$4.92M–
Q2 FY2018Jun 30, 2018-$1.77M–
Q1 FY2018Mar 31, 2018-$1.58M–
Q4 FY2017Dec 31, 2017-$1.11M–
Q3 FY2017Sep 30, 2017-$141.03K–
Q2 FY2017Jun 30, 2017-$947.30K–

More Equillium figures

See a number that looks wrong?